Oscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly Earnings

Key Highlights

• Oscar Health shares jumped approximately 11% during pre-market hours following the announcement of a record $679 million quarterly profit.
• Earnings per share on an adjusted basis reached $2.07, significantly outperforming the $1.06 consensus forecast.
• Quarterly revenue totaled $4.65 billion, below the $4.91 billion projection but representing a 53% increase from the prior year.
• Total membership across Individual and Small Group plans expanded by 57%, hitting 3.17 million members.
• The company’s medical loss ratio saw substantial improvement, dropping to 70.5% compared to 75.4% in the same quarter last year.

Oscar Health Inc. delivered its strongest quarterly financial performance to date on Wednesday, propelling OSCR shares up approximately 11% before the opening bell.

The health insurance company reported net income of $679 million, translating to $2.07 per diluted share — a substantial increase from $275 million, or $0.92 per share, recorded in the first quarter of 2025.

This result exceeded analyst expectations of $1.06 adjusted EPS by nearly double.

Oscar Health, Inc., OSCR

Quarterly revenue reached $4.65 billion, marking a 53% surge compared to $3.05 billion in the year-ago period. However, the figure came in below Wall Street’s anticipated $4.91 billion.

Management reaffirmed its complete 2026 annual guidance across every metric, demonstrating strong conviction in the company’s trajectory.

Explosive Member Growth Drives Performance

Oscar’s membership base for Individual and Small Group plans reached 3.17 million by the end of March, up sharply from 2.02 million in the comparable period last year — representing a 57% year-over-year jump.

This expansion was supported in part by the company’s entry into Alabama and Mississippi, increasing Oscar’s footprint to 20 states for the 2026 coverage year.

The insurer currently maintains operations across 573 counties spanning 93 metropolitan markets nationwide.

Industry-Leading Efficiency in Medical Spending

The company’s medical loss ratio — which measures the portion of premium dollars allocated to medical claims — improved significantly to 70.5% from 75.4% in the first quarter of 2025.

This metric stands considerably lower than the mid-to-high 80% range reported by numerous competing health insurers during the identical timeframe.

Oscar attributed this performance to strategic pricing discipline and positive prior period reserve adjustments totaling $68 million.

The company’s selling, general, and administrative expense ratio also improved, declining to 15.2% from 15.8%.

Adjusted EBITDA soared to $727 million, representing more than a doubling from the $329 million achieved in Q1 2025.

Operating earnings similarly more than doubled, climbing to $704 million compared to $297 million.

Oscar had operated at a loss throughout most of its history following its 2012 launch. The company achieved its first full-year profit in 2024 under Bertolini’s leadership, who assumed the CEO role in 2023 after previously heading Aetna.

The post Oscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly Earnings appeared first on Blockonomi.